Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
The post-initiation stage of hepatocarcinogenesis was investigated in carcinogen-resistant inbred DRH rats and the parental strain, carcinogen-sensitive Donryu rats. Male rats at 5 weeks of age from both strains were treated with N-nitrosodiethylamine (200 mg/kg i.p.) followed by feeding with a diet containing 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) from 2 weeks later and were then subjected to partial hepatectomy at 1 week later. At 8 weeks after the start of treatment, the mean area occupied by glutathione S-transferase placental form (GST-P)-positive lesions was about 30% in Donryu rats but less than 4% in DRH rats despite the presence of comparable numbers of foci in the livers of both strains. These observations suggested that clonal expansion of GST-P-positive foci in DRH rat liver was significantly suppressed under these conditions. Furthermore, this genetic property was dominantly inherited in the F1 rats by crosses of DRH and carcinogen-sensitive inbred F344 rats; that is, the induction of GST-P mRNA in the livers of F344 x DRH F1 rats was dominantly suppressed after administration of 3'-Me-DAB for 8 weeks as compared with parental F344 rats under the same conditions. We compared the intrinsic properties related to growth potential of liver cells between adult DRH and Donryu rats. DRH rat liver showed retarded and/or reduced DNA synthesis after partial hepatectomy or a single i.v. injection of lead nitrate and lower activity of telomerase induced by 3'-Me-DAB administration for 1 week, as compared with the Donryu rat liver. The intrinsic properties observed in this study may be related, at least in part, to the low incidence of liver tumors induced by hepatocarcinogens in DRH rats.
Denda
A
A
Department of Oncological Pathology, Cancer Center, Nara Medical University, Kashiwara, Japan.
Kitayama
W
W
Konishi
Y
Y
Yan
Y
Y
Fukamachi
Y
Y
Miura
M
M
Gotoh
S
S
Ikemura
K
K
Abe
T
T
Higashi
T
T
Higashi
K
K
D000818:Animals; D015152:Blotting, Northern; D001835:Body Weight / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects / Q000235:genetics; D003433:Crosses, Genetic; D004247:DNA / Q000096:biosynthesis; D004052:Diethylnitrosamine; D005982:Glutathione Transferase / Q000235:genetics / Q000378:metabolism*; D006498:Hepatectomy; D007854:Lead / Q000494:pharmacology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000201:enzymology* / Q000235:genetics*; D008297:Male; D008749:Methyldimethylaminoazobenzene; D009566:Nitrates / Q000494:pharmacology; D009929:Organ Size / Q000187:drug effects; D011230:Precancerous Conditions / Q000139:chemically induced / Q000201:enzymology*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D019098:Telomerase / Q000378:metabolism
D009566:Nitrates; D012333:RNA, Messenger; D007854:Lead; D004052:Diethylnitrosamine; D008749:Methyldimethylaminoazobenzene; C017461:lead nitrate; D004247:DNA; D005982:Glutathione Transferase; D019098:Telomerase